BioInvent International

22,40 SEK

+3,94%

Mindre end 1K følgere

BINV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Kvartalsdata

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for BioInvent International

Q4/242024Q1/25Q2/25Q3/25Q4/252025Q1/26
Omsætning21,444,722,1198,13,33,0226,513,4
EBITDA-121,0-451,8-117,734,1-128,8-119,5-331,8-116,9
EBIT-125,9-471,1-122,834,1-133,6-129,4-351,7-121,8
EBIT-%-589,0 %-1.054,1 %-556,6 %17,2 %-4.023,1 %-4.285,1 %-155,3 %-907,2 %
Overskud før skat-116,8-429,2-116,638,9-129,1-125,6-332,5-119,2
Netto indkomst-116,9-429,4-116,638,8-129,2-125,8-332,9-119,2